Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Advanced imaging of cardiac sarcoidosis.

Schatka I, Bengel FM.

J Nucl Med. 2014 Jan;55(1):99-106. doi: 10.2967/jnumed.112.115121. Epub 2013 Nov 14. Review.

2.

Early detection of cardiac sarcoid lesions with (18)F-fluoro-2-deoxyglucose positron emission tomography.

Ohira H, Tsujino I, Sato T, Yoshinaga K, Manabe O, Oyama N, Nishimura M.

Intern Med. 2011;50(11):1207-9. Epub 2011 Jun 1.

3.

Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.

Ohira H, Birnie DH, Pena E, Bernick J, Mc Ardle B, Leung E, Wells GA, Yoshinaga K, Tsujino I, Sato T, Manabe O, Oyama-Manabe N, Nishimura M, Tamaki N, Dick A, Dennie C, Klein R, Renaud J, deKemp RA, Ruddy TD, Chow BJ, Davies R, Hessian R, Liu P, Beanlands RS, Nery PB.

Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):259-69. doi: 10.1007/s00259-015-3181-8. Epub 2015 Sep 11.

PMID:
26359191
4.

Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.

Ohira H, Tsujino I, Ishimaru S, Oyama N, Takei T, Tsukamoto E, Miura M, Sakaue S, Tamaki N, Nishimura M.

Eur J Nucl Med Mol Imaging. 2008 May;35(5):933-41. Epub 2007 Dec 15.

PMID:
18084757
5.

Assessment of cardiac sarcoidosis with advanced imaging modalities.

Orii M, Imanishi T, Akasaka T.

Biomed Res Int. 2014;2014:897956. doi: 10.1155/2014/897956. Epub 2014 Aug 28. Review.

6.

Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography--magnetic resonance imaging for the diagnosis of cardiac disease.

White JA, Rajchl M, Butler J, Thompson RT, Prato FS, Wisenberg G.

Circulation. 2013 Jun 4;127(22):e639-41. doi: 10.1161/CIRCULATIONAHA.112.001217. No abstract available.

7.

Diagnostic Value of PET in Cardiac Sarcoidosis.

Smedema JP, van Kroonenburgh MJ, Snoep G, Bekkers SC, Gorgels AP.

J Nucl Med. 2004 Nov;45(11):1975. No abstract available.

8.

Combination of 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in assessing cardiac sarcoidosis.

Ishimaru S, Tsujino I, Sakaue S, Oyama N, Takei T, Tsukamoto E, Tamaki N, Nishimura M.

Sarcoidosis Vasc Diffuse Lung Dis. 2005 Oct;22(3):234-5. No abstract available.

PMID:
16315788
9.

The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis.

Mc Ardle BA, Leung E, Ohira H, Cocker MS, deKemp RA, DaSilva J, Birnie D, Beanlands RS, Nery PB.

J Nucl Cardiol. 2013 Apr;20(2):297-306. doi: 10.1007/s12350-012-9668-9. Epub 2013 Jan 4. Review.

PMID:
23288545
10.

¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis.

Ohira H, Tsujino I, Yoshinaga K.

Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1773-83. doi: 10.1007/s00259-011-1832-y. Epub 2011 May 11. Review.

PMID:
21559980
11.

18F-FDG PET/CT for the assessment of myocardial sarcoidosis.

Skali H, Schulman AR, Dorbala S.

Curr Cardiol Rep. 2013 Apr;15(4):352. Review.

12.

Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.

Tezuka D, Terashima M, Kato Y, Toriihara A, Hirasawa K, Sasaoka T, Yoshikawa S, Maejima Y, Ashikaga T, Suzuki J, Hirao K, Isobe M.

J Card Fail. 2015 Apr;21(4):313-22. doi: 10.1016/j.cardfail.2014.12.004. Epub 2014 Dec 13.

PMID:
25512195
13.

Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques.

Pandya C, Brunken RC, Tchou P, Schoenhagen P, Culver DA.

Eur Respir J. 2007 Feb;29(2):418-22.

14.

Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.

Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, Kazemian P, Kwong RY, Tokuda M, Skali H, Padera R, Hainer J, Stevenson WG, Dorbala S, Di Carli MF.

J Am Coll Cardiol. 2014 Feb 4;63(4):329-36. doi: 10.1016/j.jacc.2013.09.022. Epub 2013 Oct 16.

15.
16.

(18)F-FDG PET/CT for the assessment of myocardial sarcoidosis.

Skali H, Schulman AR, Dorbala S.

Curr Cardiol Rep. 2013 May;15(5):352. doi: 10.1007/s11886-013-0352-8. Review.

PMID:
23504346
17.

Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis.

Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, Kamigaki M, Ito N, Ohira H, Ikeda D, Tamaki N, Nishimura M.

Eur Heart J. 2005 Aug;26(15):1538-43. Epub 2005 Apr 4.

PMID:
15809286
18.

Clinical Characteristics of Late Gadolinium Enhancement in Patients with Cardiac Sarcoidosis.

Matsumoto K, Ehara S, Sakaguchi M, Otsuka K, Hasegawa T, Shimada K, Yoshiyama M.

Osaka City Med J. 2015 Jun;61(1):9-17.

PMID:
26434101
19.

Advances in radionuclide imaging of cardiac sarcoidosis.

Kouranos V, Wells AU, Sharma R, Underwood SR, Wechalekar K.

Br Med Bull. 2015 Sep;115(1):151-63. doi: 10.1093/bmb/ldv033. Epub 2015 Aug 26. Review.

PMID:
26311504
20.

Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.

Orii M, Hirata K, Tanimoto T, Ota S, Shiono Y, Yamano T, Matsuo Y, Ino Y, Yamaguchi T, Kubo T, Tanaka A, Akasaka T.

Heart Rhythm. 2015 Dec;12(12):2477-85. doi: 10.1016/j.hrthm.2015.06.032. Epub 2015 Jun 22.

PMID:
26111805

Supplemental Content

Support Center